tirzepatide vs. ozempic (semaglutide) and Mounjaro (tirzepatide) are GLP-1 receptor agonists (and in the case of tirzepatide, a dual GLP-1/GIP agonist). These drugs were originally developed for type 2 diabetes management. π¬ How they What Happens When You Switch
Description
In addition, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight in individuals with a BMI 27 kg/m 2 [149]
Is the concern physical fatigue
How much muscle do you lose on a GLP-1, and can you prevent it
Prospective patients who are comfortable operating in that space, with clinician guidance, may find this platform aligns with their approach
